Gabriel Steg

Gabriel Steg


  • Professor of Cardiology at Université Paris – Diderot, since 1994.
  • Professor at the National Heart and Lung Institute, Imperial College, London, UK since 2013.
  • Interventional cardiologist and Chief, Department of Cardiology, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, in Paris, France.
  • Director of the “Clinical Research in Atherothrombosis” Research Team, which belongs to INSERM Unit U1148, Paris
  • co-coordinator of the Département Hospitalo-Universitaire FIRE (Fibrosis, Inflammation and REmodeling) affiliated with INSERM, Université Paris-Diderot and Assistance Publique – Hôpitaux de Paris. Coordinator of the iVASC (InnoVations in Atherothrombosis SCience) research consortium.
  • Chair of the FACT (French Alliance for cardiovascular Clinical Trials) academic research network.
  • Chairman of the French National University Council for Cardiology since 2016.
  • Member of the Antithrombotic Trials Leadership and Steering (ATLAS) Group since 2013.


Dr Steg received the silver medal of the European Society of Cardiology in 2011.


Dr Steg is currently chair/co-chair or principal investigator of several large clinical trials or registries, such as ODYSSEY- Outcomes, CLARIFY, THEMIS, REALITY, SCORED, and participates in the leadership of many trials in coronary artery disease. He was co-chair of the REACH registry, co-chair of the GRACE registry publication committee and participated in numerous DMCs or CECs.


Dr Steg has authored > 1 000 articles in peer-reviewed international journals. His H-Index is 104 (Web of Science) and he has > 73 000 citations. He was a Thomson Reuters/Clarivate Analytics  ”highly cited researcher” in Clinical Medicine every year since 2014.

He is associate editor for Circulation and member of the editorial boards for Circulation: Cardiovascular Interventions, the European Heart Journal. He is currently Faculty Head, Cardiovascular Disorders, Faculty of 1000-Prime. Dr Steg co-chaired with Dr James the ESC task force in charge of the 2012 Guidelines for management of ST-segment elevation myocardial infarction.